Similar Papers

Paper Title
Journal
Date
Author
Advancing together and moving forward: Combination gene and cellular immunotherapies
Saul J Priceman ... Prasad S Adusumilli
Molecular Therapy - Oncolytics | VOL. 25
Saul J Priceman, et. al.Saul J Priceman ... Prasad S Adusumilli
30 May 2022
Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma
Shizhen Lei ... Haihui Li
Current Eye Research | VOL. 47
Shizhen Lei, et. al.Shizhen Lei ... Haihui Li
29 Mar 2022
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W Bridle ... Yonghong Wan
Molecular Therapy | VOL. 18
Byram W Bridle, et. al.Byram W Bridle ... Yonghong Wan
01 Aug 2010
BioKnife, a uPA Activity-dependent Oncolytic Sendai Virus, Eliminates Pleural Spread of Malignant Mesothelioma via Simultaneous Stimulation of uPA Expression
Yosuke Morodomi ... Fumihiro Shoji
Molecular Therapy | VOL. 20
Yosuke Morodomi, et. al.Yosuke Morodomi ... Fumihiro Shoji
01 Apr 2012
View more papers

More From: Cancer letters

Paper Title
Journal
Date
Author
Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer.
Zhuozhuo Wu ... Zhongmin Wang
Cancer letters | VOL. 617
Zhuozhuo Wu, et. al.Zhuozhuo Wu ... Zhongmin Wang
01 May 2025
Targeting of COPⅠ elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma.
Zehong Chen ... Li Zhang
Cancer letters | VOL. -
Zehong Chen, et. al.Zehong Chen ... Li Zhang
01 May 2025
Spatial distribution and activation changes of T cells in pancreatic tumors according to KRAS mutation subtype.
Ji Hye Jeong ... Eunsung Jun
Cancer letters | VOL. 618
Ji Hye Jeong, et. al.Ji Hye Jeong ... Eunsung Jun
01 May 2025
Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research
Ruici Yang ... Weiren Huang
Cancer Letters | VOL. -
Ruici Yang, et. al.Ruici Yang ... Weiren Huang
01 May 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.